Sunday, 8 April 2012

Novo Nordisk says diabetes drug Victoza superior to Merck rival

COPENHAGEN (Reuters) - Danish Novo Nordisk, the world's biggest insulin producer, said on Friday it had received a product label update for diabetes drug Victoza to include data showing superior efficacy when compared with rival drug Januvia from Merck.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/N7MZX1ts_LU/us-novonordisk-idUSBRE8350IQ20120406

auto insurance pasadena ca santa monica water damage setting up airport network

No comments:

Post a Comment